The Role of Purchasers and Payers in the Clinical Research Enterprise Workshop Summary (2002) / Chapter Skim
Currently Skimming:
Appendix III: Purchaser Payer Background Information
Appendix III: Purchaser Payer Background Information
Pages 94-96
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 94... ...
Of the $5.3 billion NIH spends on clinical research an estimated $1.9 billion is spent on clinical trials. Other government agencies add at most $1.4 billion dollars (including: Veterans Affairs, Department of Defense, Agency for Healthcare Research and Quality, Centers for Disease Control, Health Resources and Services Administration, and Centers for Medicare and Medicaid Services, and Food and Drug Administration)
|
From page 95... ...
Increased medical inflation Increased prescription drug costs Strong demand for medical services Growth in technology including information technology investments The top disease categories based on cost or utilization indicators include: Cancer, Ischemic heart disease, Congestive Heart Failure, Injury, Complications of Medical and Surgical care, Complications of Pregnancy, Psychiatric Conditions, and Asthma (Table 1~. A survey of 20 licensed HMO plans that published research in the public domain and had a specific infrastructure to support research, had 1996 revenue of $92 million and employed 1,273 staff.6 The selected plans covered more than 29 million members.
|
From page 96... ...
96 so so ° U:)
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.